MedPath

Mood, serotonin and social interactio

Completed
Conditions
Depression
Mood disorder
10027946
Registration Number
NL-OMON36285
Lead Sponsor
Rijksuniversiteit Groningen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

Age 18-65 years. At least one first-degree family member with MDD (FH+) or no first- and second-degree family members with MDD (FH-). Willingness to cooperate; to sign written informed consent.

Exclusion Criteria

Any current or past DSM-IV Axis I mood disorder, anxiety disorder, psychotic disorder, eating disorder, or somatoform disorder as determined by SCID-NP interview. Any current substance use disorder. Any past substance dependence. Ongoing medical treatment for a chronic disease, particularly cancer, gastrointestinal disease, phenylketonurea, diabetes, cardiovascular disease, or disease of the liver or kidneys. Not speaking Dutch fluently. Current or past use of neuroleptics, sedative drugs, antidepressants etc. On test days, a positive urine test for drugs of abuse. For women, initiation of hormonal contraceptive treatments <= 3 months prior to screening, or a positive urine test for pregnancy on test days

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Primary outcome is empathic accuracy measured with an empathic accuracy task<br /><br>(EAT). </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Secondary outcome measures are the amount of behavioural mimicry, speech<br /><br>characteristics, heart rate variability (HRV), scores on the Positive and<br /><br>Negative Affect Schedule (PANAS) and Visual Analogue Scale (VAS). Finally,<br /><br>polymorphisms of genes thought to be related to MDD are analysed.</p><br>
© Copyright 2025. All Rights Reserved by MedPath